Page 17 - Annual Report 2020

npj PRECISION ONCOLOGY
- Springer Nature launched the journal “npj Precision Oncology” in partnership with The Hormel Institute, University of Minnesota in Austin, Minnesota, United States.
- npj Precision Oncology, is a new open access, international, peer-reviewed journal that publishes cutting edge scientific research in all aspects of precision oncology, from basic
science to translational applications to clinical medicine.
- The journal defines precision oncology as cancer diagnosis, prevention, and/or treatment tailored specifically to the individual patient based on their genetic and/or molecular profile. - npj Precision Oncology fills the need of a journal where both preclinical and early clinical studies can be published together to help support this rapidly advancing field.
- According to the Managing Editor at Nature Research “Npj Precision Oncology has been exceptionally successful”. We have passed the first landmark of 25 peer-reviewed published articles, which makes our journal eligible to apply for inclusion in PUBMED, one of the first steps required to obtain an IMPACT FACTOR. We are also looking for 1-2 additional Associate Editors to bring on board.
- Featured topics include cancer development and prevention, therapies that target specific cellular pathways, cancer metabolism and genetic risk factors.
- In addition to publishing original basic science, translational and clinical research articles, npj Precision Oncology -also publishes case reports, brief communications, commentaries, perspectives, and review articles.
- The journal also publishes a professionally written Editorial Lay Summary to accompany each research Article, which summarizes the key issues being addressed within the article aimed to keep readership at the vanguard of new discoveries in the field.
Please visit us at: https://www.nature.com/npjprecisiononcology/